Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
CCF
|
Adam Chase
President/CEO |
SELL
Open market or private sale
|
Indirect | 1,000 Reduced 0.49% |
$100,430
$100.43 p/Share
|
Jan 04
2021 |
|
CDLX
|
Scott D. Grimes
Director |
SELL
Open market or private sale
|
Indirect | 2,000 Reduced 0.4% |
$276,220
$138.11 p/Share
|
Jan 04
2021 |
|
JOUT
|
Thomas F Pyle Jr
Director |
SELL
Open market or private sale
|
Direct | 2,981 Reduced 6.32% |
$334,647
$112.26 p/Share
|
Jan 04
2021 |
|
NTGR
|
Patrick Cs Lo
Chief Exective Officer |
SELL
Open market or private sale
|
Direct | 25,806 Reduced 20.57% |
$1,020,369
$39.54 p/Share
|
Jan 04
2021 |
|
NTGR
|
Michael F Falcon
Chief Operations Officer |
SELL
Open market or private sale
|
Direct | 518 Reduced 0.8% |
$21,181
$40.89 p/Share
|
Jan 04
2021 |
|
NTGR
|
Andrew Wonki Kim
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 518 Reduced 0.69% |
$21,181
$40.89 p/Share
|
Jan 04
2021 |
|
NTGR
|
Tamesa Rogers
Chief People Officer |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 7.78% |
$119,250
$39.75 p/Share
|
Jan 04
2021 |
|
RLMD
|
Charles J Casamento
Director |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 12.02% |
$96,330
$32.11 p/Share
|
Jan 04
2021 |
|
OPRX
|
Douglas P Baker
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 8,334 Reduced 9.19% |
$274,022
$32.88 p/Share
|
Jan 04
2021 |
|
ARCT
|
Pad Chivukula
Chief Scientific Officer & COO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 1.44% |
$464,000
$46.4 p/Share
|
Jan 04
2021 |
|
INO
|
Simon X Benito
Director |
SELL
Open market or private sale
|
Direct | 2,750 Reduced 5.06% |
$24,750
$9.0 p/Share
|
Jan 04
2021 |
|
PSTL
|
Patrick R Donahoe
Director |
SELL
Open market or private sale
|
Direct | 2,600 Reduced 6.02% |
$43,264
$16.64 p/Share
|
Jan 04
2021 |
|
ADAP
|
John Lunger
Chief Patient Supply Officer |
SELL
Open market or private sale
|
Direct | 1,065 Reduced 37.7% |
$5,676
$5.33 p/Share
|
Jan 04
2021 |
|
ADAP
|
William C Bertrand Jr
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 3,499 Reduced 37.37% |
$18,650
$5.33 p/Share
|
Jan 04
2021 |
|
ADAP
|
Elliot Norry
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 845 Reduced 37.77% |
$4,504
$5.33 p/Share
|
Jan 04
2021 |
|
ADAP
|
Adrian Rawcliffe
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 4,967 Reduced 42.44% |
$26,474
$5.33 p/Share
|
Jan 04
2021 |
|
CURO
|
Donald Gayhardt
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 1.9% |
$197,400
$13.16 p/Share
|
Jan 04
2021 |
|
GALT
|
10 X Fund, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 0.16% |
$22,300
$2.23 p/Share
|
Jan 04
2021 |
|
WATT
|
Brian J Sereda
Senior Vice President & CFO |
SELL
Open market or private sale
|
Direct | 4,471 Reduced 1.59% |
$8,450
$1.89 p/Share
|
Jan 04
2021 |
|
WATT
|
Neeraj Sahejpal
Senior VP, Product Marketing |
SELL
Open market or private sale
|
Direct | 3,682 Reduced 1.35% |
$6,959
$1.89 p/Share
|
Jan 04
2021 |
|
WATT
|
Rahul G. Patel
Director |
SELL
Open market or private sale
|
Direct | 9,589 Reduced 27.72% |
$18,123
$1.89 p/Share
|
Jan 04
2021 |
|
WATT
|
Cesar Johnston
Director |
SELL
Open market or private sale
|
Direct | 8,562 Reduced 2.28% |
$16,182
$1.89 p/Share
|
Jan 04
2021 |
|
MLSS
|
Leonard Osser
Director |
SELL
Open market or private sale
|
Direct | 71,886 Reduced 1.7% |
$165,338
$2.3 p/Share
|
Jan 04
2021 |
|
AQMS
|
Judd Merrill
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 41,773 Reduced 9.88% |
$140,357
$3.36 p/Share
|
Jan 04
2021 |
|
AQMS
|
Stephen Cotton
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 69,874 Reduced 6.01% |
$234,777
$3.36 p/Share
|
Jan 04
2021 |
|
TYME
|
Michael Demurjian
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 0.08% |
$25,600
$1.28 p/Share
|
Jan 04
2021 |
|
CLXT
|
Daniel F Voytas
Chief Science Officer |
SELL
Open market or private sale
|
Direct | 2,513 Reduced 100.0% |
$10,379
$4.13 p/Share
|
Jan 04
2021 |
|
NAV
|
Stephen R. D'Arcy
Director |
SELL
Open market or private sale
|
Direct | 2,156 Reduced 22.04% |
$95,058
$44.09 p/Share
|
Jan 04
2021 |
|
NRG
|
Elizabeth R Killinger
Exec VP, NRG Home |
SELL
Open market or private sale
|
Direct | 31,543 Reduced 20.4% |
$1,164,252
$36.91 p/Share
|
Jan 04
2021 |
|
AVTR
|
Gerard Brophy
EVP, Biopharma Production |
SELL
Open market or private sale
|
Direct | 59,418 Reduced 23.82% |
$1,654,197
$27.84 p/Share
|
Jan 04
2021 |
|
NRG
|
Robert J Gaudette
Exec VP, NRG Business |
SELL
Open market or private sale
|
Direct | 11,197 Reduced 13.96% |
$413,281
$36.91 p/Share
|
Jan 04
2021 |
|
PLAB
|
Richelle E Burr
EVP, CAO, GC & Secretary |
SELL
Open market or private sale
|
Direct | 3,225 Reduced 2.58% |
$36,088
$11.19 p/Share
|
Jan 04
2021 |
|
PLAB
|
Christopher J Progler
EVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 2.0% |
$33,570
$11.19 p/Share
|
Jan 04
2021 |
|
NEM
|
Thomas Ronald Palmer
President & CEO |
SELL
Open market or private sale
|
Direct | 5,150 Reduced 2.08% |
$319,043
$61.95 p/Share
|
Jan 04
2021 |
|
NEM
|
Robert D Atkinson
EVP & COO |
SELL
Open market or private sale
|
Direct | 1,347 Reduced 1.57% |
$83,447
$61.95 p/Share
|
Jan 04
2021 |
|
NEM
|
John Kitlen
VP, Controller & CAO |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 5.94% |
$123,900
$61.95 p/Share
|
Jan 04
2021 |
|
SQ
|
Jack Dorsey
Block Head and Chairperson |
SELL
Open market or private sale
|
Indirect | 100,000 Reduced 54.8% |
$22,131,000
$221.31 p/Share
|
Jan 04
2021 |
|
PEN
|
Thomas Wilder
Director |
SELL
Open market or private sale
|
Direct | 115 Reduced 43.73% |
$20,047
$174.32 p/Share
|
Jan 04
2021 |
|
PEN
|
Harpreet Grewal
Director |
SELL
Open market or private sale
|
Direct | 633 Reduced 4.93% |
$110,345
$174.32 p/Share
|
Jan 04
2021 |
|
PEN
|
James Robert Pray
President, International |
SELL
Open market or private sale
|
Indirect | 5,000 Reduced 0.17% |
$877,200
$175.44 p/Share
|
Jan 04
2021 |
|
NVDA
|
Jen Hsun Huang
President and CEO |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 7.35% |
$53,253,998
$532.54 p/Share
|
Jan 04
2021 |
|
KO
|
Nancy Quan
Executive Vice President |
SELL
Open market or private sale
|
Direct | 2,102 Reduced 1.15% |
$114,055
$54.26 p/Share
|
Jan 04
2021 |
|
AMT
|
Samme L Thompson |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 8.95% |
$452,140
$226.07 p/Share
|
Jan 04
2021 |
|
AFL
|
Joseph L Moskowitz
Director |
SELL
Open market or private sale
|
Direct | 100 Reduced 0.59% |
$4,460
$44.6 p/Share
|
Jan 04
2021 |
|
GTE
|
Gmt Capital Corp
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 275,924 Reduced 0.43% |
$99,333
$0.36 p/Share
|
Jan 04
2021 |
|
CMG
|
Pershing Square Capital Management, L.P.
Director |
SELL
Open market or private sale
|
Indirect | 37,548 Reduced 3.23% |
$50,062,374
$1333.29 p/Share
|
Jan 04
2021 |
|
SHPW
|
Glazer Capital, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 0.45% |
$103,000
$10.3 p/Share
|
Jan 04
2021 |
|
DEN
|
Goldentree Asset Management LP
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 87,444 Reduced 0.8% |
$2,354,867
$26.93 p/Share
|
Jan 04
2021 |
|
PLTR
|
Alexander C. Karp
Director |
SELL
Open market or private sale
|
Direct | 1,285,123 Reduced 16.66% |
$30,251,797
$23.54 p/Share
|
Jan 04
2021 |
|
BGNE
|
Baker Bros. Advisors LP |
SELL
Open market or private sale
|
Indirect | 121,154 Reduced 1.03% |
$26,714,457
$220.5 p/Share
|
Jan 04
2021 |